The trophic effect of continuous intraventricular infusion of nerve growth factor (NGF) on morphology of the basal forebrain (BF) cholinergic neurons was tested in 4-
dence for preservation of BF cholinergic neurons from atrophy during aging and indicate that senile impairment of the cholinergic system in rats concerns decrease in ChAT-protein expression rather than an acute degeneration of neuronal cell bodies. Treatment with NGF resulted in restoration of cholinergic phenotype in the BF neurons of aged rats. However, the present study also rises issue of possible detrimental effects of NGF in young normal animals.
Much present-day neurobiological research points to the difference between normal and pathological aging of the nervous system (Dani et al., 1997) . Normal aging is generally regarded as involving mild morphological, biochemical and physiological changes, which lead to slowing down of the normal function of the nervous system. The results of pathological aging are the neurodegenerative diseases, defined as progressive loss of neurons and extensive deterioration of cognitive and intellectual functions. During normal aging selective degeneration of neurons occurs in some parts of the cortex and non-cortical areas of the brain. However, there is in fact no substantial evidence that neuronal loss appears on a large scale as a universal effect throughout the whole brain. It is estimated that, in the cortex, very few neurons become lost with age (Cragg 1975 ; Pakkenberg & Gundensen, 1997; Peters et al., 1998) , and that this does not drastically affect cortical functions. Moreover, the effect of normal aging on the subcortical nuclei that modulate the function of neocortical regions is still incompletely understood. A similar caution should be applied to the basal forebrain cholinergic system which plays an important role in learning and attentional processes of mammalian central nervous system. In rodents an age-dependent decline in acetylcholine synthesis (Dravid, 1993; Gibbson & Peterson, 1981; Springer et al., 1987; Strong et al., 1990) , acetylcholine release (Rama Sastry et al., 1983 ) and high-affinity choline uptake (Gilad et al., 1987) have been observed in various forebrain regions, and there is morphological evidence of cholinergic neuron atrophy, which in some cases is accompanied by cell loss, in the septal-diagonal band area, nucleus basalis and striatum (Dekker et al., 1992; Altavista et al., 1990 ). Degeneration of basal forebrain cholinergic neurons is also found in aged nonhuman primates (Flood & Coleman, 1988; Hayashi, 1996) and in patients suffering from Alzheimer's disease (Whitehous et al., 1982; Allen et al., 1988; Francis et al., 1994) . Progressive loss of cholinergic neuronal functions during aging is frequently associated with learning and memory impairment suggesting that normal cognitive function is dependent on integrity of the central cholinergic ascending system (Gallagher & Pelleymounter, 1988; Mandel et al., 1989; Olton et al., 1991) .
Proper function of cholinergic neurons is dependent on a continuous supply of target-derived trophic factors such as the nerve growth factor (NGF) (Korsching, 1986 ; Thoenen et al., 1987; Whittemore & Seiger, 1987; Sofroniew & Cooper, 1993 ; Knusel & Hefti, 1993) . These neurons express NGF receptors, TrkA and p75 NTR (Koh et al., 1989; Schattemann et al., 1988 ) and respond to NGF by increased activity of the acetylcholine synthesizing enzyme, choline acetyltransferase (ChAT) (Mobley et al., 1985; Cavicchioli et al., 1989; Hefti et al., 1989; Martinez et al., 1989) . In NGF and TrkA knockout animals basal forebrain cholinergic neurons persist but they appear to be atrophic and show reduced synthesis of choline acetyltransferase and reduced axonal branching (for review see Snider, 1994) . Although target-derived NGF does not regulate the survival of mature cholinergic neurons, the existent evidence suggests that the production of ChAT, cell size, and terminal arborization of those neurons are regulated by NGF (Sofroniew et al., 1990) . The age-related reduction in NGF accessibility probably contributes to the pronounced vulnerability of cholinergic neurons 314 G. Niewiadomska and others 2000
to degeneration during aging and in Alzheimer's disease (Cooper et al., 1994; Scott et al., 1995) . The behavioral impairments which are associated with marked atrophic changes in the basal forebrain cholinergic system can be ameliorated by infusion of exogenous NGF. Intracerebroventricular infusion of NGF prevents the memory loss and degeneration of cholinergic neurons in septum and diagonal band following fimbria-fornix transections in rats (Will & Hefti, 1985; Williams et al., 1986; Kromer 1987; Montero & Hefti, 1989; Tuszynski et al., 1990; Koliatsos et al., 1991a) and in nonhuman primates (Koliatsos et al. 1991b; Tuszynski et al., 1991; Kordower et al., 1994) . In aged rats, intraventricular infusions of NGF reverse cholinergic neuronal atrophy in the basal forebrain and the concomitant memory impairment (Fischer et al., 1987; 1991; Markowska et al., 1994; MartinezSerrano et al., 1995; 1996; Backman et al., 1996; Castel-Barthe et al., 1996) , suggesting that age-related pathological brain dysfunction might be ameliorated by treatment with neurotrophic factor.
Most of earlier studies usually estimated degenerative or atrophic changes in morphology of the cholinergic neurons. However, recently attention has been focused on the idea that, during normal aging, cholinergic neurons do not die at first but undergo phenotypic changes (Smith et al., 1999) due to disordered neurotransmitter biosynthesis. Age-related reduction in ChAT-immunoreactivity was often interpreted as indicative of cell atrophy or death but age-dependent loss of enzyme activity, which could occur without true cell degeneration, is also possible. In aged rats, infusion of NGF could reverse age-related impairment in ChAT expression rather than prevent acute degeneration of neuronal cell bodies per se. Therefore, the present study was undertaken to examine the specificity and magnitude of the age-associated changes in characteristics of the basal forebrain cholinergic neurons in a normal non-selected population of senescent rats, and to determine the influence of exogenous NGF infusion on the morphology and physiology of the cholinergic system.
MATERIAL AND METHODS

Animals.
Young and aged male Wistar rats were maintained in a colony room with food and water available ad libitum in the home cage. All studies were conducted using behaviorally uncharacterized animals from the same breeding colony. The rats were sub-divided randomly into treated and untreated groups. Each experimental group of rats is identified by an abbreviation describing the age (4 months old, and 28 months old rats at the time of morphological analysis) and type of treatment (con -control vehicle treated, and NGF -NGF-solution treated rats). Each treated and each control group consisted of five rats. The animal care procedures adhered to institutional guidelines and the Local Ethics Commission at the Nencki Institute.
Surgery. Rats were anesthetized with a mixture of 62.5 mg/kg ketamine and 3.2 mg/kg xylazine dissolved in 0.9% sterile saline. After anesthesia the rats were mounted in a small animal stereotaxic apparatus (David Kopf, Tujunga, CA, U.S.A.) with bregma and lambda in the same horizontal plane. In sterile conditions a burr hole was made 0.5 mm posterior to bregma and 1.6 mm lateral to the midline. A 28-gauge stainless steel cannula (4.5 mm dorsoventrally from dura) was lowered stereotaxically to the right lateral ventricle. The cannula was connected to subcutaneously implanted osmotic minipump (Alzet 2004, Alza Co., Palo Alto, CA, U.S.A.) via silastic tubing to secure one-month continuous delivery of substances. The pumps were filled with 220 ml/pump either NGF (2.5S from mouse salivary gland, Boehringer, Mannheim; NGF groups) or vehicle solution (artificial cerebrospinal fluid containing 100 mg/ml rat serum albumin; control groups).
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Tissue preparation. Animals were deeply anesthetized with Nembutal and the perfusion procedure was begun when all reflex responses to cutaneous stimulation were absent. Tissues were fixed by intraaortic perfusion with 0.9% NaCl followed by a mixture of 4% paraformaldehyde and 15% picric acid in 0.1 M phosphate buffer, pH 7.4, and then followed by cold phosphate-buffered 5% glycerol with 2% Me 2 SO. The brains were removed and placed for 1h in the fixative solution and then immersed for cryoprotection in 10% followed by 20% glycerol + 2% Me 2 SO. For immunohistochemical analysis, brains were positioned in a brain matrix (BAS Inc., Lafayette U.S.A.) to evenly sliced into uniform blocks. Sections were cut coronally through the forebrain at 40 mm thickness with a freezing stage microtome. Sixty consecutive sections were collected throughout the basal forebrain region (from 0.48 mm anterior to -2.12 mm posterior to bregma (Paxinos & Watson, 1997) ) of each rat. From five series of the sections collected, one set of twelve was processed for ChAT immunoreactivity (ChAT-ir), the second set for p75 NTR immunoreactivity (p75 NTR -ir), the third for Cresyl Violet Nisslstaining, and the fourth for histochemical detection of acetylcholinesterase (AChE), and the fifth corresponding series of sections were stored at -20°C in a cryoprotective solution as a reserve. The results of earlier studies (Smith et al., 1993; Smith & Booze, 1995) revealed that no age-related changes in distribution of ChAT-ir cells were found along the anterior-posterior axis of the main basal forebrain (BF) areas. Based on these findings, the same number of stored brain sections from both young and aged animals was taken for the analysis.
Immunohistochemistry. For immunohistochemical determination of ChAT, a monoclonal antibody commercially supplied by Boehringer Mannheim (Germany) was used at 10 mg/ml dilution. The free-floating sections were incubated in Tris/HCl buffer with the primary antibody, with continuous agitation at room temperature overnight and subsequently were similarly incubated in a goat anti-rat biotin conjugated antibody (ICN Immunobiologicals, Irvine, CA, U.S.A.) for 1 h followed by peroxidase conjugated streptavidin (The Binding Site Lmt., England) for 1 h. Following a brief (5 min) reaction with 0.05% diaminobenzidine (DAB) in the presence of 0.01% hydrogen peroxide the sections were mounted on glass microscope slides, air-dried, dehydrated in alcohol/xylene serial solutions and coverslipped with permanent mounting media. After each incubation sections were washed 3 times for 5 min. For p75 NTR , a rat monoclonal anti-nerve growth factor-receptor antibody (Boehringer Mannheim, Germany) was adjusted to a working concentration 5 of mg/ml. As above, the sections were incubated with agitation at room temperature overnight with the primary antibody, subsequently incubated in a biotinylated sheep anti-mouse immunoglobulin solution (The Binding Site Lmt., England) for 1 h and then in peroxidase conjugated streptavidin. The peroxidase was visualized with DAB. Controls were routinely run in the absence of primary antibodies in the first step as a safeguard against nonspecific staining by the primary antibody.
Histochemistry. Target areas of the cholinergic BF neurons, such as the hippocampus, the olfactory bulb, the cortex and the amygdala, displayed a high density of AChE-positive fibers. AChE is generally used as a marker for putative cholinergic cortical fibers in rodent and nonhuman primate brain. Many studies indicated that, in most cortical areas, the pattern of AChE-positive fiber staining is similar to that of ChAT-ir fiber staining (e.g. Lysakowski et al., 1989; Baskerville et al., 1993) . Thus, also in the present study, the histochemical reactivity of AChE was used as a marker for cholinergic projection to the cortex. To illustrate the data obtained, an example of somatic sensorimotor cortex was presented. In addition, detection of AChE activity, which in basal forebrain is predominantly localized to the cholinergic cells, served as an additional control of the presence of cholinergic neurons in the BF. AChE was estimated by histochemical method of Geneser-Jansen & Blackstad (1971). Sections were incubated in the reaction media at room temperature for 5 h. In control experiment, a second set of slices was processed in an incubation media with addition of either ethopropazine methosulphate (10 -5 M) as selective pseudocholinesterases inhibitor or 1,5-bis(4-allydimethylammoniumphenyl)pentan-3-dibromide (BW284c51). The addition of ethopropazine did not affect fibre or cell body staining, while the histochemical reaction was completely blocked with BW284c51. Thus, formation of the reaction-product described in our studies below was due to the activity of specific cholinesterase (AChE). A computer image analysis was used for quantitation of the intensity of staining measured across the entire cortical depth.
Computer-assisted microscopic mapping and morphological analysis. For the final analysis, slide series from 5 animals of each group were selected as representative among the multiple series that were processed. Sections were viewed with a Nikon Optiphot microscope equipped with an x/y movementsensitive stage and video camera attached to an IBM PC Pentium. A computerized image analysis technique (MCID, Imaging Research Inc., Canada, digitizer and software) was used for the morphometric and densitometric analysis of ChAT-and p75-immunoreactive neurons in the medial septum (MS), in the vertical (VDB) and horizontal (HDB) limb of the diagonal band, in the substantia innominata (SI), and in the magnocellular basal nucleus (NBM). Identification of the investigated brain areas was confirmed by referring to the atlas of rat brain by Paxinos & Watson (1997) .
The boundaries of the structures in the coronal plane were determined microscopically and marked on line drawings using a computer-aided X-Y plotting system. Counting of the number of neuronal profiles in each outlined area and measurements of their square area (morphometric parameter), as well as intensity of their staining (ROD -relative optical density, semiquantitative densitometric parameter developed by the software) was done at 400´magnification. All consecutive sections of each series were analyzed. The neuronal counts were summarized using the mean neuronal numerical density per unit area analyzed. Thus, data are presented as unmodified neuronal cells counts per region under study, which are mean values from serial consecutive brain sections of five rats in each group. For the morphometric analysis neurons were defined as immunolabeled cell bodies when the best in focus cell nucleus and one or two dendrites were well visible within the counting frame. These criteria were used to exclude from the analysis any population of non-complete remnants of neurons. Neuronal counts were performed by two independent observers (inter-observer correlation r = 0.81). Statistical analysis. All data were analyzed by parametric methods and expressed as means ±S.E.M. The morphometric and densitometric data was compared by two-way ANOVA followed by post-hoc Newman-Keuls Vol. 47 NGF and forebrain cholinergic neurons in aged rats 317 test. The analysis was made using STA-TISTICA software at P < 0.05 level of significance.
RESULTS
General observations
In the present study numerical responses of ChAT-immunoreactive (ChAT-ir) neurons in the basal forebrain differed from those noted for p75-immunoreactivity (p75-ir). All animals showed a clear cytoplasmic immunoreactivity for p75
NTR receptor in BF neurons and their morphology appeared unchanged in aged rats. The cell bodies were densely stained, with tapering varicose dendrites forming an intensely stained neuropil (Fig. 1d , e, f). This was not the case with ChAT immunostaining.
While in the young adult group neurons stained well (Fig. 1a) , in no rat from the 28-month-old control group well visible ChAT immunostaining was observed. The number of ChAT immunostainable neurons in 28-month-old rats was lower than in young adult group consisting 50-70% for the control. The remaining ChAT-ir cells appeared shrunken with markedly reduced neuropil staining (Fig. 1b) . Infusion of NGF increased the number of ChAT-ir cells in the 28-month-old group to about 90% of that for young control (Fig. 1c) . In all NGF treated animals of the aged group dense immunolabeling of ChAT-ir cells was observed. On the contrary, NGF did not influence the morphology of p75-ir cells in aged animals ( Fig. 1f ), which were labeled well irrespective of the treatment. The population of large neurons in the basal magnocellular nucleus of the aged rats which had lost the ability to be stained for ChAT, still was labeled very well in Nissl staining and did not express distinct atrophic changes (Fig. 1g, h, i) .
Morphometry of basal forebrain neurons in young and aged untreated rats
ChAT-ir neurons
In the 28-month-old control rats, the number of ChAT-ir cells was reduced as compared to the 4-month-old group. The loss of ChAT-ir neurons in aged rats was most pronounced in the SI-NBM region where a 67% reduction in the number of immunolabeled cells was observed ( Fig. 2) (P < 0.0006). In all forebrain regions analyzed, the size of the remaining ChAT-ir cell bodies was significantly reduced in the aged control rats when compared with the young controls (Fig. 3A) . The reduction in mean cross-sectional area of ChAT-ir neurons amounted to 11% in MS (137.2 ± 33.8 vs 153.9 ± 37.9 mm 2 ; n = 339; P < 0.03), 23% in VDB The measurement of the densitometric parameter, the relative optical density (ROD) of immunolabeling (Fig. 3B) , revealed an even more essential difference in morphology of ChAT-ir cells between young and aged control rats than the analysis of cell size. Aging resulted in a significant reduction in the intensity of immunostaining for ChAT in all BF structures. The overall decrease in ROD of the aged rats when compared with the young ones was 35% in MS (0.31 ± 0.08 vs 0.47 ± 0.09; P < 0.0002), 41% in VDB (0.19 ± 0.07 vs 0.32 ± 0.07; P < 0.00006), 25% in HDB (0.28 ± 0.06 vs 0.37 ± 0.1; P < 0.001) and 35% in SI-NBM (0.25 ± 0.05 vs 0.38 ± 0.08; P < 0.00003). Different results were obtained with the p75 NTR antibody, which selectively stains the cholinergic neurons in the basal forebrain structures. In the aged control rats no significant reduction in the number of p75-ir cells was observed in the SI-NBM region (Fig. 2) . In addition, the mean cross-sectional area of p75-ir neurons did not differ significantly between aged and young control groups (MS = 153.9 ± 30.6 vs 162. (Fig. 4A ).
Quite comparable data were obtained from analysis of the ROD parameter, which describes the intensity of immunostaining for the p75 NTR . The strong perikaryal immunoreactivity in the basal forebrain neurons was unchanged in the aged control rats when compared with the young ones (MS = 0.51 ± 0.06 vs 0.43 ± 0.09; VDB = 0.32 ± 0.05 vs 0.35 ± 0.07; HDB = 0.37 ± 0.08 vs 0.38 ± 0.08; SI-NBM = 0.41 ± 0.1 vs 0.41 ± 0.07) (Fig. 4B) . Moreover, visualization of neuronal morphol-
Figure 2. Mean number (±S.E.M.) of ChAT-and p75-immunoreactive and Nissl stained neurons in the substantia innominata -magnocellular basal nucleus (SI-NBM) in young (4-month-old) and aged (28-month-old) untreated rats and in young (4-month-old) and aged (28-month-old) NGFtreated animals.
Difference in ChAT-ir cell number of young and aged untreated rats, significant at P <0.0006 (*); and in control and aged NGF-treated animals, significant at P <0.005 (**).
ogy with the p75 NTR antibody revealed that the BF neurons of aged rats did not display any atrophic or degenerative changes.
Nissl stained neurons
The number of all Nissl-stained neurons in the SI-NBM region was quantified within the same anatomical boundaries within which ChAT-ir and p75-ir cells were counted. There was no significant decline in the number of Nissl-stained cell bodies in aged control rats compared with young subjects (Fig. 2) . Careful analysis of Nissl-stained brain sections revealed no signs of degeneration of large basal forebrain neurons (Fig. 1g, h, i) . Although we did not observe any neuronal shrinkage or neuronal loss in any of the basal areas, on comparing young normal rats with aged ones, we cannot exclude the existence of relatively small quantitative differences in perikaryal size or neuronal density.
Reversibility of age-related morphological changes in BF neurons by NGF treatment
The reduction in the number of ChAT-ir neurons in aged rats was partially or completely reversed by chronic NGF infusion. The effect of NGF was observed not only on the side of the neurotrophic factor infusion (right hemisphere), but also in the contralateral hemisphere (not shown). In aged NGF-treated rats the number of ChAT-ir cell bodies, quantified as means per unit area of SI-NBM, was restored to about 95% of values in young untreated controls, an amount that did not differ between groups (475.5 ± 27.9 vs 499.6 ± 31.1). However, there was a significant difference in the number of ChAT-ir neurons between aged control and NGF-treated rats (208.5 ± 29.7 vs 499.6 ± 31.1; P < 0.003), which exhibited an increase of 63% in neuronal number compared with untreated subjects (Fig. 2) .
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Figure 3. Mean cross-sectional area (A) and relative optical density (ROD) (B) (±S.E.M.) of ChAT-immunoreactive neurons in young (4-month-old) and aged (28-month-old) untreated rats and in young (4-month-old) and aged (28-month-old) NGF-treated animals.
The data were compared in four basal forebrain regions: the medial septal nucleus (MS), the vertical (VDB) and horizontal (HDB) limb of the diagonal band, and the substantia innominata -magnocellular basal nucleus (SI-NBM). Difference in mean cross-sectional area of young and aged untreated rats, significant at P (*) and of aged control and aged NGF-treated rats significant at P(**); difference in mean ROD of young untreated and young NGF-treated rats; significant at P(z); difference in mean ROD of young and aged untreated rats significant at P(v) and of aged control and aged NGF-treated rats, significant at P(vv).
The size of ChAT-ir neurons in aged NGF-treated rats was comparable with that of young control ones (Fig. 3A) and did not differ. Furthermore, the immunolabeled ChAT neurons of all tested regions were significantly larger in the 28-month-old rats treated with NGF than in the 28-month-old vehicle-treated controls. The overall increase in mean cross-sectional area was about 18% in MS (162.5 ± 33.8 vs 137.2 ± 37.9 mm 2 ; n = 239; P < 0.001), 30% in VDB (193.7 ± 38.1 vs 148.5 ± 36.7 mm 2 ; n = 624; P < 0.0001), 21%
in HDB (191.1 ± 43.3 vs 157.6 ± 39.3 mm 2 ; n = 863; P < 0.001) and 21% in SI-NBM (208.9 ± 42.3 vs 172.3 ± 47.5 mm 2 ; n = 786; P < 0.001).
In aged rats treatment with NGF resulted in a significant increase in the intensity of immunostaining for ChAT. The enhancement in ROD values amounted to 17% in MS (0.37 ± 0.09 vs 0.31 ± 0.08; P < 0.001), 46% in VDB (0.35 ± 0.09 vs 0.19 ± 0.07; P < 0.0006), 20% in HDB (0.35 ± 0.09 vs 0.28 ± 0.06; P < 0.001) and 40% in SI-NBM (0.41 ± 0.09 vs 0.25 ± 0.05 P < 0.00002) (Fig. 3B) . In contrast, treatment with NGF decreased significantly the intensity of ChAT immunostaining in the basal cholinergic neurons of young 4-month-old rats. This reduction was about 13% in MS (0.41 ± 0.07 vs 0.47 ± 0.09; n = 434; P < 0.002), 10% in VDB (0.29 ± 0.08 vs 0.32 ± 0.07; n = 7 24; P < 0.01), 30% in HDB (0.26 ± 0.06 vs 0.37 ± 0.1; n = 962; P < 0.00003) and 16% in SI-NBM (0.32 ± 0.08 vs 0.38 ± 0.08; n = 996; P < 0.0003) as compared with the young untreated animals (Fig. 3B) . No difference in cell number and size between NGF-treated and vehicle control groups was observed when the measurements were done for p75-ir neurons ( Fig. 2 and 4A) . The NGF infusion did not change the intensity of p75 NTR immunostaining, except for the aged rats (Fig. 4B) . In young NGF-treated subjects the loss of p75 NTR immunoreactivity in the basal forebrain neurons matched the loss of ChAT immunoreactivity and was statistically significant. The overall decrease in ROD was 14% in MS (0.44 ± 0.09 vs 0.51 ± 0.06; P < 0.01), 10% in VDB (0.29 ± 0.07 vs 0.32 ± 0.05; P < 0.02), 14% in HDB (0.32 ± 0.08 vs 0.37 ± 0.08; P < 0.01), and 22% in SI-NBM (0.32 ± 0.07 vs 0.41 ± 0.1; P < 0.004).
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As in untreated rats, the number of Nissl-stained neurons of SI-NBM in young and aged NGF-treated rats did not differ significantly.
Acetylcholinesterase (AChE) fiber staining in brain cortex Figure 5 shows the results of AChE staining in the forelimb (S1FL) and hindlimb (S1HL) areas of parietal cortex in young and aged untreated rats and in NGF-treated animals. In young control rats three AChE active bands were observed: a superficial band in layer I, a moderately dense band within layer III, and a third band, thicker and dark, corresponding to the layer V-VI (Fig. 5B, in the left vertical  panel) . The pattern of AChE labeling in the aged control rats differed from that of young animals. Namely, although three bands of staining distributed in layer I, III, and V-VI were also distinguished, their overall intensity was clearly lower than that in the young rats (Fig. 5B, in the middle vertical panel) . Intraventricular infusion of NGF enhanced the intensity of AChE staining in parietal cortex of aged rats in which three relatively dense bands of AChE activity were observed (Fig.  5B, in the right vertical panel) . There were no pronounced changes in the intensity of AChE staining in NGF-treated young rats compared with the untreated animals (not shown). The laminar pattern of enzyme activity in cortical layers (B) is reflected by relative optical density (ROD) measured through the cortex with an image processing system (A). Photomicrographs of adjacent Nissl stained sections depicting cortical lamination of area S1HL-S1FL are included for reference (C). To match correctly cortical lamination in (B) Nissl stained sections were placed as mirror images. Bar = 200 mm.
DISCUSSION
In the present study we focused on the morphology of the neuronal elements of the basal forebrain cholinergic system in a normal population of non-selected aged rats. In the 28-month-old control rats, ChAT positively stained neurons showed significant decrease of both cell size and cell number. The intensity of ChAT immunostaining was also lower in aged rats. However, it should be emphasized that the population of large neurons in the basal forebrain of aged rats, which had lost the ability to ChAT staining was still labeled very well for p75 NTR receptor and did not express distinct atrophic changes of cell bodies and processes. These observations were confirmed also by analysis of Nissl staining. Thus, both our ChAT-ir and p75-ir studies provide evidence for survival of the basal cholinergic neurons in aged rats. The concept that cortical neurons are lost with age and that this was a basis of cognitive decline, was embedded in our knowledge for years. However, the reported counts of the cells in the cortex (Cragg, 1975 Double et al., 1996) show that very few cells are lost during normal aging. In the studies of Pakkenberg & Gundensen (1997) on humans, which covered the age range from 20 years to 90 years, only 10% of all neocortical neurons were lost over the life span in either sexes. Similarly, when comparisons were made with laboratory animals, primates (Herndon et al., 1998; Peters, 1997) and rodents (Pugnaloni et al., 1998) , there is no strong evidence to support the concept that significant numbers of neurons are lost from cerebral cortex with age. Instead, it appears that cortical neurons are largely preserved. Thus, the cognitive deficits that arise during normal aging in humans, in non-human primates, and rodents could not be linked with an overall loss of cortical neurons.
However, it cannot be ruled out that there may be a dramatic loss of one of the specific populations of cortical neurons or neurons in non-cortical structures of the brain, which are important for learning and memory. Among these structures, basal forebrain cholinergic neurons have been extensively studied, particularly because of their degeneration during Alzheimer's disease (for example see Quirion, 1993) . These cholinergic neurons project to the entire cortical mantle where they have been proposed to exert an integrative influence on information processing in the neocortex. Indeed, the telencephalic cholinergic complex is one of the most diffusely projecting neuronal systems in the brain, and it is generally considered an important central integrator in cognitive brain function. The loss of cortical cholinergic innervation during aging has been attributed to the loss of cholinergic cell groups present in the basal forebrain (Fischer et al., 1987; 1991; Vogels et al., 1990; Chen & Gage, 1995) . Some recent immunohistochemical studies on the BF report, however, on only changes in size of the neurons (Backmann et al., 1996) . On the other hand, atrophy of these cells has been described (Martinez-Serrano et al., 1996; Smith et al., 1999) .
The results of the current experiments are in general agreement with previous studies indicating that the integrity of basal forebrain cholinergic neurons is destroyed in aged rodents. Such earlier studies which were based on AChE histochemical localization or ChAT immunoreactivity (Kromer, 1987; Rosenberg et al., 1988; Cuello et al., 1989; Fischer et al., 1987; 1991) have usually reported the decline in the markers associated with perikarya of neurons, and concluded that this led to neuronal atrophy or death. However, based on the evidence presented above, it seems unjustified to conclude that a significant portion of cholinergic neurons degenerates with age. Cell shrinkage and reduction in cell number was observed only for ChAT immunostained neurons but not for p75 NTR stained neurons.
It is notable that p75 NTR is expressed mainly, although not exclusively, by cholinergic neuVol. 47 NGF and forebrain cholinergic neurons in aged ratsrons in the basal forebrain (Pioro & Cuello, 1990) and that BF level of p75 NTR protein or its mRNA is not changed in old age or in Alzheimer's disease (Mufson et al., 1999; Cooper et al., 1994) . Thus, immunostaining for p75 NTR could serve as a more than marker of cholinergic neurons. In agreement with those evidences, our data strongly suggest that forebrain cholinergic neurons do not lose their morphological integrity on aging. Apparent cell atrophy or cell loss reported earlier might have been wrongly identified on the basis of phenotypic changes in histochemical markers that do not detect true boundaries of the cell. Cell shrinkage and staining intensity can change independently during aging. Our results seem to indicate that senile impairment of the cholinergic system in rats concerns an age-related loss of choline acetyltransferase expression and that the possible down-regulation of ChAT could not lead to neuronal death. Early studies led to the conclusion that there was a significant loss of neurons with age in subcortical structures. However, recent studies on aging in rats seem to confirm our presented results. There are indications that also neurons in the brain structures others than neocortex are largely preserved with age although their function is changed. Rapp & Gallagher (1996) counted neuron numbers of representative samples of the entire hippocampus of behaviorally tested aged rats, and they reported that there was no age-related loss of neurons, even in the rats with the greatest age-related behavioral impairments. Hippocampal cell numbers were also evaluated in young and aged rats submitted to chronic unpredictable stress or corticosterone treatment (Sousa et al., 1998) . Neither stress nor treatment with corticosterone was found to result in significant cell losses in any division of the hippocampal formation, either in young or aged rats; likewise, neither treatment produced significant volumetric differences. Moreover, the numbers of neurons did not differ in the two age groups of experimental rats. Age-related morphological and functional changes were also studied in the medial mamillary nuclei of the hypothalamus (Begega et al., 1999) . The number of neurons and glial cells remained unchanged with aging but there was an age-dependent reduction in medial mamillary nuclei volume and a decrease of neuronal activity and protein synthesis in this region. Similarly, in rats examined between the age of 3 and 23 months, no loss of cells was observed in cerebellum (Huang et al., 1999) . Nevertheless, serious morphological changes pointing to functional losses were found. The cerebella of aged rats lost 30% of the thickness of the molecular layer, 60% of the length of parallel fibers, and 80% of the synaptic varicosities along parallel fibers.
Since the first demonstration of the rescue of degenerating basal forebrain cholinergic neurons (Hefti et al., 1984) by exogenously applied NGF a great many studies have confirmed this biological activity in a number of species including primates (Liberini & Cuello, 1994) . The results with rats, to which NGF was administered directly into the ventricle via minipumps, coincide with other studies (Kromer, 1987; Rosenberg et al., 1988; Cuello et al., 1989; Fischer et al., 1991) suggesting that the target-derived trophic factor is important for maintenance of the basal forebrain cholinergic projection system. Age-related decline in the number and size of ChAT-immunoreactive neuron, and, particularly, in the intensity of their staining were reversed by NGF infusion in all experimental subjects. The effect of NGF on the number and size of detectable ChAT-ir neurons in the basal forebrain of aged rats suggests that improvement by NGF was not related to survival of BF neurons but to a more specific action of NGF, such as more pronounced cholinergic phenotype of those neurons. NGF-mediated increase in the ChAT activity was first found in cell cultures prepared from fetal or neonatal rat septum (Gnahan et al., 1983; Hatanaka et al., 1988; Takei et al., 1988 In untreated aged rats, a number of network of AChE-positive cortical fibers was markedly reduced in the cortical areas. However, after administration of NGF the pattern of cortical AChE activity resembled that of young rats. Therefore, we conclude that, in aged rats, the cholinergic cells are not dying or becoming atrophic but rather are in a quiescent state. The observation that infusion of NGF reverses the quiescent state of cholinergic neurons might suggest that a local deficit of the trophic factor is, at least, partly responsible for deterioration of cholinergic phenotype and cortical projection of those neurons. However, there is no consistent loss of NGF or NGF mRNA during aging or in dementia of Alzheimer's type (Hellweg & Hartung, 1990; . It is possible that impairment with age of axonal transport, as observed in peripheral (Caselli et al., 1999; Lopez et al., 1998; Ma et al., 2000) and septohippocampal (Linke & Frotscher, 1993) nerves, can influence the availability of NGF, which is delivered to the cholinergic perikarya by retrograde transport. In aged rats, substantially fewer (Cooper et al., 1994) basal forebrain cholinergic neurons take up and retrogradely transport NGF from its target region. In addition, expression of the high affinity NGF receptor, TrkA, is significantly reduced in the basal forebrain of the aged rats (Mufson et al., 1997; . High affinity binding of NGF has been reported to be reduced in the cerebral cortex of aged rats (Alberch et al., 1991) . Taken together, these findings suggest that certain basal forebrain cholinergic neurons in aged rats may undergo intrinsic changes, leading to a failure of NGF signaling and, in consequence to perturbations in cholinergic projection of those neurons. The sustained NGF production, unaltered or even increased in the aged brain appears to be unable to prevent this deterioration in the forebrain cholinergic nuclei, possibly because of a diminished capacity of the NGF-sensitive neurons to bind or transport NGF in age rats.
In the majority of young adult rats, infusion of NGF caused a decrease in the intensity of ChAT and p75 NTR immunostaining, however, did not influence the size of the cholinergic neurons. The neural basis of such an effect remains unclear. It may be due to different sensitivity of cholinergic neurons of normal adult rats to NGF as compared with that of aged animals. Alternatively, the exogenous application of NGF may lead to an excessive level of trophic factor in young subjects. This supraoptimal administration of NGF may be injurious for normal adult cholinergic neurons. Similar results were observed in behavioral studies (Markowska et al., 1994) in which NGF infusion impaired choice accuracy of young adult rats in the recent memory task and ameliorated age-related deterioration in learning of old rats.
In conclusion, our results indicate that, in rats, cholinergic neurons of the basal forebrain survive during aging, but are not detectVol. 47 NGF and forebrain cholinergic neurons in aged rats 325 able by ChAT immunohistochemical method. NGF, when supplied locally to the brain tissue in high pharmacological doses, permits to evaluate the level of expression of ChAT in this tissue and exerts its improving effect on the cholinergic neurons even if administered to rat brain at a very late phase of aging.
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